| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/17/2011 | US7943619 Isoxazolo-pyridazine derivatives |
| 05/17/2011 | US7943618 Btk protein kinase inhibitors |
| 05/17/2011 | US7943617 Heterobicyclic compounds useful as kinase inhibitors |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943615 Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes |
| 05/17/2011 | US7943613 Compounds, their preparation and use |
| 05/17/2011 | US7943612 Compounds that modulate PPAR activity, their preparation and use |
| 05/17/2011 | US7943611 Imidazo[1,2-A]pyridin-3-yl-acetic acid hydrazides, processes, for their preparation and pharmaceutical uses thereof |
| 05/17/2011 | US7943610 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 05/17/2011 | US7943609 Chiral fused [1,2]imidazo[4,5-C] ring compounds |
| 05/17/2011 | US7943608 Diazepinoes |
| 05/17/2011 | US7943607 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 05/17/2011 | US7943606 Compositions and methods to control abnormal cell growth |
| 05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/17/2011 | US7943604 Method of treating human skin and a skin care composition for use in such a method |
| 05/17/2011 | US7943603 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 05/17/2011 | US7943602 Pharmaceutical application of 15- or 16-substituted testosterone analogues |
| 05/17/2011 | US7943601 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs |
| 05/17/2011 | US7943600 Antimicrobial combination therapy |
| 05/17/2011 | US7943599 Sesamol derivatives or their salts, the process for preparing the same, and the skin external composition containing the same |
| 05/17/2011 | US7943598 Use of organic glucosamine salts |
| 05/17/2011 | US7943597 Phosphate-binding chitosan and uses thereof |
| 05/17/2011 | US7943596 Pharmaceutical composition for dry eye, which remains on the cornea and exhibits a humectant effect for a longer period |
| 05/17/2011 | US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 05/17/2011 | US7943594 Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans |
| 05/17/2011 | US7943593 Compositions comprising inhibitors of IMPDH enzyme |
| 05/17/2011 | US7943592 RNAi inhibition of alpha-ENaC expression |
| 05/17/2011 | US7943590 Compositions and methods for treating ophthalmic disorders |
| 05/17/2011 | US7943589 siRNA microbicides for preventing and treating diseases |
| 05/17/2011 | US7943586 Antineoplastic agents targeted via glut transporters |
| 05/17/2011 | US7943585 Extended release antibiotic composition |
| 05/17/2011 | US7943584 Medicinal composition containing diabetes remedy |
| 05/17/2011 | US7943583 2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it |
| 05/17/2011 | US7943582 Canagliflozin, a sodium-glucose transporter 2 inhibitor as antiobesity, antidiabetic agent; purity; handling characteristics; easy formulation; storage stability |
| 05/17/2011 | US7943575 Sustained release drug formulations containing a carrier peptide |
| 05/17/2011 | US7943560 Cyclopropanated macrocyclic ketones and lactones |
| 05/17/2011 | US7943370 Structure, target substance detection element and target substance detection kit |
| 05/17/2011 | US7943338 Autoimmune conditions and NADPH oxidase defects |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943312 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 05/17/2011 | US7943186 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight |
| 05/17/2011 | US7943184 Process for preparing an extract from ivy leaves |
| 05/17/2011 | US7943176 Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 05/17/2011 | US7943174 Controlled release hydrocodone formulations |
| 05/17/2011 | US7943173 Pharmaceutical combinations of oxycodone and naloxone |
| 05/17/2011 | US7943170 immediate release phase and a sustained release phase of paracetamol, which has a unique in vitro dissolution profile; suitable for treating both acute pain such as dental pain or headache and chronic pain, such as the pain associated with arthritis. |
| 05/17/2011 | US7943166 transient receptor potential vanilloid-1 (TRPV1) such as capsaicin; for reducing nociceptive nerve fiber function; topical application |
| 05/17/2011 | US7943159 Female sex pheromone of the dogwood borer (DWB), Synanthedon scitula, and attraction inhibitor (antagonist) |
| 05/17/2011 | US7943157 copolymer based on acryloxydimethyltaurine; water soluble, water swelling |
| 05/17/2011 | US7943120 Olefin wax, silicone-modified olefin wax, silicone-modified room temperature-solidifying composition using the wax, and cosmetics using them |
| 05/17/2011 | US7943118 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 05/17/2011 | US7942958 Composite biocidal particles |
| 05/17/2011 | US7942147 Aerosol forming device for use in inhalation therapy |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2582722C Intestinal polyp inhibitor |
| 05/17/2011 | CA2560844C Pharmaceutical agent containing hyaluronan as an active ingredient |
| 05/17/2011 | CA2558313C New expression tools for multiprotein applications |
| 05/17/2011 | CA2514267C Malonamide derivatives as gamma-secretase inhibitors |
| 05/17/2011 | CA2498944C Amino alcohol derivatives, salts thereof and immunosuppressive agents |
| 05/17/2011 | CA2496763C Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 05/17/2011 | CA2494574C 7-phenylpyrazolopyridine compounds |
| 05/17/2011 | CA2493496C Antiaging composition |
| 05/17/2011 | CA2490157C Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2484374C Medical products comprising a haemocompatible coating, production and use thereof |
| 05/17/2011 | CA2479919C Powder formulations suitable for inhalation |
| 05/17/2011 | CA2473790C 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/17/2011 | CA2465077C Improved delivery of multiple doses of medications |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/17/2011 | CA2458351C Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 05/17/2011 | CA2453418C Variolin derivatives and their use as antitumor agents |
| 05/17/2011 | CA2440726C Substituted benzofuran-2-carboxamides derivatives |
| 05/17/2011 | CA2437994C Crystalline forms of pyrimidine nucleoside derivative |
| 05/17/2011 | CA2437851C 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 05/17/2011 | CA2425489C Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2414484C Muscle-strengthening drugs and anti-inflammatory drugs |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2411409C Vitamin d derivatives |
| 05/17/2011 | CA2402446C 1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor activity |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/17/2011 | CA2394717C Iron chelator delivery system |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/17/2011 | CA2376339C Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 05/17/2011 | CA2228221C Papillomavirus polyprotein constructs |
| 05/17/2011 | CA2197672C Tetrahydrofuran antifungals |
| 05/17/2011 | CA2114267C Use of oxidase inhibitor with dextromethorphan to treat intractable coughing and dermatitis |
| 05/13/2011 | CA2685638A1 Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin |
| 05/13/2011 | CA2685636A1 Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
| 05/12/2011 | WO2011057269A2 Compositions for enhancing hair growth |
| 05/12/2011 | WO2011057262A2 Treatment of infections with tp receptor antagonists |
| 05/12/2011 | WO2011057241A2 Androstenediol as an indicator for assessing estrogenicity |
| 05/12/2011 | WO2011057220A2 Compositions and methods for treating lymphoma |
| 05/12/2011 | WO2011057215A1 Novel inhibitors of hepatitis c virus replication |
| 05/12/2011 | WO2011057209A1 Acidic ophthalmic formulations |
| 05/12/2011 | WO2011057208A2 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/12/2011 | WO2011057204A2 Lrrk2-mediated neuronal toxicity |
| 05/12/2011 | WO2011057183A1 Nutritional supplements for relief of dry eye |